mdt: the income statement

MyFinsight

For the quarter ending 2025-07-25, MDT made $8,578M in revenue. $1,040M in net income. Net profit margin of 12.12%.

Unit: Million (M) dollars (except for numbers of shares and EPS)

Income Statement	2025-07-25	2025-01-24	2024-10-25	2024-07-26
Net sales	8,578	8,292	8,403	7,915
Selling, general, and administrative expense	2,806	2,717	2,757	2,655
Research and development expense	726	675	697	676
Other operating expense, net	-70	5	34	-1
Certain litigation charges, net	27	22	0	81
Cost of products sold, excluding amortization of intangible assets	3,001	2,779	2,946	2,761
Amortization of intangible assets	459	416	413	414
Restructuring charges, net	45	43	30	47
Operating profit	1,445	1,646	1,595	1,278
Other non-operating income, net	33	72	173	157
Interest expense, net	176	179	209	167
Income before income taxes	1,302	1,540	1,559	1,268
Income tax provision	255	237	281	220
Net income	1,047	1,303	1,278	1,049
Net income attributable to noncontrolling interests	7	9	9	6
Net income attributable to medtronic	1,040	1,294	1,270	1,042

Basic earnings per share (in dollars per share)	0.81	1.01	0.99	0.81
Basic weighted average shares outstanding (in shares)	1,281,600,000	1,282,400,000	1,282,400,000	1,293,300,000
Diluted earnings per share (in dollars per share)	0.81	1.01	0.99	0.8
Diluted weighted average shares outstanding (in shares)	1,287,100,000	1,286,200,000	1,286,900,000	1,296,500,000